White Collar Defense & Government Investigations AlertIntroduction
In April 2024, following a jury trial in federal court in Northern California, Matthew Panuwat, a former executive at a biopharma company, was found liable for insider trading. The case, which was filed in 2021 by the U.S. Securities and Exchange Commission (SEC), involved so-called “shadow trading” by Panuwat, who, while in possession of material nonpublic information (MNPI) about his employer, Medivation (Company A), traded...
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.